Eisai Co., Ltd. (OTCMKTS:ESALY – Get Free Report)’s stock price passed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $61.51 and traded as high as $63.29. Eisai shares last traded at $61.51, with a volume of 331,800 shares trading hands.
Eisai Stock Performance
The stock has a fifty day moving average of $61.51 and a 200-day moving average of $61.51. The stock has a market cap of $17.64 billion, a PE ratio of 70.70, a price-to-earnings-growth ratio of 2.46 and a beta of 0.31. The company has a quick ratio of 1.77, a current ratio of 2.20 and a debt-to-equity ratio of 0.10.
About Eisai
Eisai Co, Ltd. is a research-driven global pharmaceutical company headquartered in Tokyo, Japan. Founded in 1941 by Toyoji Naito, Eisai focuses on the discovery, development, manufacture and commercialization of prescription medicines and related healthcare products. The company emphasizes neuroscience and oncology as core therapeutic areas and invests in both small-molecule and biologic research to address unmet medical needs.
Among its well-known products, Eisai developed and markets Aricept (donepezil), a widely used treatment for the symptoms of Alzheimer’s disease, and LENVIMA (lenvatinib), an oncology therapy for several tumor types.
Further Reading
- Five stocks we like better than Eisai
- 3 Tech ETFs That Could Bounce Back After the AI Selloff
- 3 Penny Stocks Under $5 Backed by Real Revenue Growth
- 3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend
- Beyond the AI Trade: 3 Defensive Stocks Built for Stability
Receive News & Ratings for Eisai Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eisai and related companies with MarketBeat.com's FREE daily email newsletter.
